Evidence map›Paper›PMID 23248270›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Activation of 5-HT2A receptors upregulates the function of the neuronal K-Cl cotransporter KCC2.

Rémi Bos, Karina Sadlaoud, Pascale Boulenguez, Dorothée Buttigieg, Sylvie Liabeuf, Cécile Brocard, Georg Haase, Hélène Bras, Laurent Vinay

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 103 papers.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 173 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Modeling cerebral palsy in animals.Developmental medicine and child neurology · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Knockdown of calpain1 in lumbar motoneurons reduces spasticity after spinal cord injury in adult rats.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Rémi BosInstitut de Neurosciences de la Timone, Unité Mixte de Recherche 7289, Centre National de la Recherche Scientifique, Aix-Marseille Université, F-13385 cx5 Marseille, France.
Karina Sadlaoud
Pascale Boulenguez
Dorothée Buttigieg
Sylvie Liabeuf
Cécile Brocard
Georg Haase
Hélène Bras
Laurent Vinay
Institut de Neurosciences de la Timone · FRAix-Marseille Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In healthy adults, activation of γ-aminobutyric acid (GABA)(A) and glycine receptors inhibits neurons as a result of low intracellular chloride concentration ([Cl(-)](i)), which is maintained by the potassium-chloride cotransporter KCC2. A reduction of KCC2 expression or function is implicated in the pathogenesis of several neurological disorders, including spasticity and chronic pain following spinal cord injury (SCI). Given the critical role of KCC2 in regulating the strength and robustness of inhibition, identifying tools that may increase KCC2 function and, hence, restore endogenous inhibition in pathological conditions is of particular importance. We show that activation of 5-hydroxytryptamine (5-HT) type 2A receptors to serotonin hyperpolarizes the reversal potential of inhibitory postsynaptic potentials (IPSPs), E(IPSP), in spinal motoneurons, increases the cell membrane expression of KCC2 and both restores endogenous inhibition and reduces spasticity after SCI in rats. Up-regulation of KCC2 function by targeting 5-HT(2A) receptors, therefore, has therapeutic potential in the treatment of neurological disorders involving altered chloride homeostasis. However, these receptors have been implicated in several psychiatric disorders, and their effects on pain processing are controversial, highlighting the need to further investigate the potential systemic effects of specific 5-HT(2A)R agonists, such as (4-bromo-3,6-dimethoxybenzocyclobuten-1-yl)methylamine hydrobromide (TCB-2).

Indexed as

AnimalsBlotting, WesternBridged Bicyclo CompoundsChloridesGene Expression RegulationH-ReflexImmunohistochemistryInhibitory Postsynaptic PotentialsK Cl- CotransportersMethylaminesMotor NeuronsMuscle SpasticityRatsReceptor, Serotonin, 5-HT2ASerotoninSerotonin 5-HT2 Receptor Agonists(4-bromo-3,6-dimethoxybenzocyclobuten-1-yl)methylamineBridged Bicyclo CompoundsChloridesK Cl- CotransportersMethylaminesReceptor, Serotonin, 5-HT2ASerotoninSerotonin 5-HT2 Receptor AgonistsSymporters

Identifiers

PMID23248270
PMCPMC3538195
OpenAlexW2072648819

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.